Baseline demographics, APOE genotypes, Brain Volumes, and 1-Year Rates of Atrophy in PiB-positive and PiB-negative individuals.

The association of genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample-0

Helen Christensen (64840)
Philip J Batterham (94836)
Andrew J Mackinnon (94837)
Anthony F Jorm (21287)
Holly A Mack (94838)
Karen A Mather (94839)
Kaarin J Anstey (94840)
Perminder S Sachdev (94841)
Simon Easteal (94842)

December 2011

function of APOE genotype and education. Panel C: Changes in SDMT as a function of APOE genotype and...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 4

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

Estimated longitudinal changes in BrainAGE scores for the 4 diagnostic groups: NO (...

Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's Disease and healthy ageing

Sauty, Benoît
Durrleman, Stanley

September 2022

Age, sex and APOE-ε4 genotype have been identified as the strongest predictors of the risk of develo...

Baseline demographics, APOE genotypes, Brain Volumes, and 1-Year Rates of Atrophy for all individuals included in the study.

K. Abigail Andrews (390126)
Marc Modat (300140)
Kate E. Macdonald (390127)
Tom Yeatman (390128)
M. Jorge Cardoso (390129)
Kelvin K. Leung (390130)
Josephine Barnes (390131)
Victor L. Villemagne (390132)
Christopher C. Rowe (224406)
Nick C. Fox (300143)
Sebastien Ourselin (300144)
Jonathan M. Schott (366655)

March 2013

NC = normal control; SD = standard deviation; CI = confidence interval; MMSE = Mini Mental State ...

Baseline demographics, APOE genotype, neuropsychometry, SUVR, brain volumes and annualised rates of atrophy in amyloid positive and negative normal controls from this study compared to ADNI amyloid positive/negative individuals defined on the basis of CSF Aβ1-42.

K. Abigail Andrews (390126)
Marc Modat (300140)
Kate E. Macdonald (390127)
Tom Yeatman (390128)
M. Jorge Cardoso (390129)
Kelvin K. Leung (390130)
Josephine Barnes (390131)
Victor L. Villemagne (390132)
Christopher C. Rowe (224406)
Nick C. Fox (300143)
Sebastien Ourselin (300144)
Jonathan M. Schott (366655)

March 2013

NC = normal control; SD = standard deviation; CI = confidence interval; MMSE = Mini Mental State ...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 7

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

ROC curves for pMCI_early subjects, analyzing individual subject classification based on b...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 2

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

BrainAGE scores at (A) baseline and (B) the last visit for non-carriers and carriers of...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 6

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

Cumulative probability for MCI patients of remaining AD-free, divided into patients with t...

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population

Riaz, M
Huq, A
Ryan, J
Orchard, SG
Tiller, J
Lockery, J
Woods, RL
Wolfe, R
Renton, AE
Goate, AM
Sebra, R
Schadt, E
Brodtmann, A
Shah, RC
Storey, E
Murray, AM
McNeil, JJ
Lacaze, P

May 2021

Few studies have measured the effect of genetic factors on dementia and cognitive decline in healthy...

Summary of sample characteristics.

Bruno A. Benitez (197732)
Celeste M. Karch (115883)
Yefei Cai (197745)
Sheng Chih Jin (449595)
Breanna Cooper (449596)
David Carrell (449597)
Sarah Bertelsen (28964)
Lori Chibnik (449598)
Julie A. Schneider (341811)
David A. Bennett (229710)
Anne M. Fagan (224128)
David Holtzman (449599)
John C. Morris (197761)
Alison M. Goate (113596)
Carlos Cruchaga (115891)

August 2013

Age at lumbar puncture (LP), percentage of females, percentage of APOE4 allele carriers, c...

Data from: ApoE is a correlate of phenotypic heterogeneity in Alzheimer's disease in a national cohort

Weintraub, Sandra
Teylan, Merilee
Rader, Benjamin M.
Chan, Kwun C.G.
Bollenbeck, Mark
Kukull, Walter
Coventry, Christina
Rogalski, Emily
Bigio, Eileen
Mesulam, Marsel

August 2020

Objective: To compare the proportion of APOEε4 genotype carriers in aphasic versus amnestic variants...

Apoe genotypes and brain imaging classes in normal cognition, mild cognitive impairment, and alzheimer’s disease: A longitudinal study

Camarda C.
Torelli P.
Pipia C.
Sottile G.
Cilluffo G.
Camarda R.

January 2020

Objective: To evaluate in 419 stroke-free cognitively normal subjects (CN) aged 45-82 years covering...

IC‐P‐099: Elevated PiB precedes dementia in autosomal dominant Alzheimer’s disease: PiB, FDG and atrophy in the DIAN cohort

Benzinger, Tammie
Blazey, Tyler
Koeppe, Robert
Jack, Clifford
Raichle, Marcus
Su, Yi
Snyder, Abraham
Marcus, Daniel
Ringman, John
Thompson, Paul
Ghetti, Bernardino
Saykin, Andrew
Salloway, Stephen
Correia, Steve
Johnson, Keith
Sperling, Reisa
Schofield, Peter
Masters, Colin
Rowe, Christopher
Villemagne, Victor
Fox, Nick
Brickman, Adam
Mayeux, Richard
Martins, Ralph
Mathis, Chester
Klunk, William
Weiner, Michael
Bateman, Randall
Fagan, Anne
Goate, Alison
Cairns, Nigel
Buckles, Virginia
Moulder, Krista
Morris, John

July 2012

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152697/1/alzjjalz201205132.pd

Demographic information for each of the diagnosis groups (normal controls (NC), mild cognitive impairment (MCI), and Alzheimer's disease (AD)) at the baseline.

Xianfeng Yang (293131)
Ming Zhen Tan (293132)
Anqi Qiu (251502)

February 2013

Note: SD – standard deviation; MMSE – mini-mental state examination; MCI-s – subjects with MCI wh...

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

Emily N Manning
Josephine Barnes
David M Cash
Jonathan W Bartlett
Kelvin K Leung
Sebastien Ourselin
Nick C Fox

To investigate whether APOE ε4 carriers have higher hippocampal atrophy rates than non-carriers in A...

The association of genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample-0

Helen Christensen (64840)
Philip J Batterham (94836)
Andrew J Mackinnon (94837)
Anthony F Jorm (21287)
Holly A Mack (94838)
Karen A Mather (94839)
Kaarin J Anstey (94840)
Perminder S Sachdev (94841)
Simon Easteal (94842)

December 2011

function of APOE genotype and education. Panel C: Changes in SDMT as a function of APOE genotype and...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 4

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

Estimated longitudinal changes in BrainAGE scores for the 4 diagnostic groups: NO (...

Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's Disease and healthy ageing

Sauty, Benoît
Durrleman, Stanley

September 2022

Age, sex and APOE-ε4 genotype have been identified as the strongest predictors of the risk of develo...

Baseline demographics, APOE genotypes, Brain Volumes, and 1-Year Rates of Atrophy for all individuals included in the study.

K. Abigail Andrews (390126)
Marc Modat (300140)
Kate E. Macdonald (390127)
Tom Yeatman (390128)
M. Jorge Cardoso (390129)
Kelvin K. Leung (390130)
Josephine Barnes (390131)
Victor L. Villemagne (390132)
Christopher C. Rowe (224406)
Nick C. Fox (300143)
Sebastien Ourselin (300144)
Jonathan M. Schott (366655)

March 2013

NC = normal control; SD = standard deviation; CI = confidence interval; MMSE = Mini Mental State ...

Baseline demographics, APOE genotype, neuropsychometry, SUVR, brain volumes and annualised rates of atrophy in amyloid positive and negative normal controls from this study compared to ADNI amyloid positive/negative individuals defined on the basis of CSF Aβ1-42.

K. Abigail Andrews (390126)
Marc Modat (300140)
Kate E. Macdonald (390127)
Tom Yeatman (390128)
M. Jorge Cardoso (390129)
Kelvin K. Leung (390130)
Josephine Barnes (390131)
Victor L. Villemagne (390132)
Christopher C. Rowe (224406)
Nick C. Fox (300143)
Sebastien Ourselin (300144)
Jonathan M. Schott (366655)

March 2013

NC = normal control; SD = standard deviation; CI = confidence interval; MMSE = Mini Mental State ...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 7

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

ROC curves for pMCI_early subjects, analyzing individual subject classification based on b...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 2

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

BrainAGE scores at (A) baseline and (B) the last visit for non-carriers and carriers of...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 6

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

Cumulative probability for MCI patients of remaining AD-free, divided into patients with t...

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population

Riaz, M
Huq, A
Ryan, J
Orchard, SG
Tiller, J
Lockery, J
Woods, RL
Wolfe, R
Renton, AE
Goate, AM
Sebra, R
Schadt, E
Brodtmann, A
Shah, RC
Storey, E
Murray, AM
McNeil, JJ
Lacaze, P

May 2021

Few studies have measured the effect of genetic factors on dementia and cognitive decline in healthy...

Summary of sample characteristics.

Bruno A. Benitez (197732)
Celeste M. Karch (115883)
Yefei Cai (197745)
Sheng Chih Jin (449595)
Breanna Cooper (449596)
David Carrell (449597)
Sarah Bertelsen (28964)
Lori Chibnik (449598)
Julie A. Schneider (341811)
David A. Bennett (229710)
Anne M. Fagan (224128)
David Holtzman (449599)
John C. Morris (197761)
Alison M. Goate (113596)
Carlos Cruchaga (115891)

August 2013

Age at lumbar puncture (LP), percentage of females, percentage of APOE4 allele carriers, c...

Data from: ApoE is a correlate of phenotypic heterogeneity in Alzheimer's disease in a national cohort

Weintraub, Sandra
Teylan, Merilee
Rader, Benjamin M.
Chan, Kwun C.G.
Bollenbeck, Mark
Kukull, Walter
Coventry, Christina
Rogalski, Emily
Bigio, Eileen
Mesulam, Marsel

August 2020

Objective: To compare the proportion of APOEε4 genotype carriers in aphasic versus amnestic variants...

Apoe genotypes and brain imaging classes in normal cognition, mild cognitive impairment, and alzheimer’s disease: A longitudinal study

Camarda C.
Torelli P.
Pipia C.
Sottile G.
Cilluffo G.
Camarda R.

January 2020

Objective: To evaluate in 419 stroke-free cognitively normal subjects (CN) aged 45-82 years covering...

IC‐P‐099: Elevated PiB precedes dementia in autosomal dominant Alzheimer’s disease: PiB, FDG and atrophy in the DIAN cohort

Benzinger, Tammie
Blazey, Tyler
Koeppe, Robert
Jack, Clifford
Raichle, Marcus
Su, Yi
Snyder, Abraham
Marcus, Daniel
Ringman, John
Thompson, Paul
Ghetti, Bernardino
Saykin, Andrew
Salloway, Stephen
Correia, Steve
Johnson, Keith
Sperling, Reisa
Schofield, Peter
Masters, Colin
Rowe, Christopher
Villemagne, Victor
Fox, Nick
Brickman, Adam
Mayeux, Richard
Martins, Ralph
Mathis, Chester
Klunk, William
Weiner, Michael
Bateman, Randall
Fagan, Anne
Goate, Alison
Cairns, Nigel
Buckles, Virginia
Moulder, Krista
Morris, John

July 2012

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152697/1/alzjjalz201205132.pd

Demographic information for each of the diagnosis groups (normal controls (NC), mild cognitive impairment (MCI), and Alzheimer's disease (AD)) at the baseline.

Xianfeng Yang (293131)
Ming Zhen Tan (293132)
Anqi Qiu (251502)

February 2013

Note: SD – standard deviation; MMSE – mini-mental state examination; MCI-s – subjects with MCI wh...

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

Emily N Manning
Josephine Barnes
David M Cash
Jonathan W Bartlett
Kelvin K Leung
Sebastien Ourselin
Nick C Fox

To investigate whether APOE ε4 carriers have higher hippocampal atrophy rates than non-carriers in A...

The association of genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample-0

Helen Christensen (64840)
Philip J Batterham (94836)
Andrew J Mackinnon (94837)
Anthony F Jorm (21287)
Holly A Mack (94838)
Karen A Mather (94839)
Kaarin J Anstey (94840)
Perminder S Sachdev (94841)
Simon Easteal (94842)

December 2011

function of APOE genotype and education. Panel C: Changes in SDMT as a function of APOE genotype and...

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease - Fig 4

Luise Christine Löwe (3154413)
Christian Gaser (51035)
Katja Franke (427897)

July 2016

Estimated longitudinal changes in BrainAGE scores for the 4 diagnostic groups: NO (...

Impact of sex and APOE-ε4 genotype on patterns of regional brain atrophy in Alzheimer's Disease and healthy ageing

Sauty, Benoît
Durrleman, Stanley

September 2022

Age, sex and APOE-ε4 genotype have been identified as the strongest predictors of the risk of develo...

Baseline demographics, APOE genotypes, Brain Volumes, and 1-Year Rates of Atrophy in PiB-positive and PiB-negative individuals.

Abstract

Extracted data

Baseline demographics, APOE genotypes, Brain Volumes, and 1-Year Rates of Atrophy in PiB-positive and PiB-negative individuals.

Abstract

Extracted data

Related items

Related items